Shopping Cart
Remove All
Your shopping cart is currently empty
Tabituximab (ONC-005) is a humanized monoclonal antibody targeting frizzled class receptor 10 (FZD10) with antitumor activity for the study of immune system diseases.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $450 | - | In Stock | |
| 5 mg | $1,400 | - | In Stock | |
| 10 mg | $2,220 | - | In Stock | |
| 25 mg | $4,210 | - | In Stock |
| Description | Tabituximab (ONC-005) is a humanized monoclonal antibody targeting frizzled class receptor 10 (FZD10) with antitumor activity for the study of immune system diseases. |
| In vitro | The non-radiolabeled Tabituximab antibody showed only weak inhibition of synovial sarcoma cell growth. [1] |
| In vivo | Yttrium-90 radiolabeled Tabituximab demonstrated significant anti-tumor effects after a single intravenous injection in a mouse xenograft model. [1] |
| Synonyms | OTSA101, OTSA 101, ONC-005, ONC005 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Host Species | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Molecular Weight | 145.5 kDa |
| Cas No. | 1644134-10-0 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.